Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis. [electronic resource]
Producer: 20040824Description: 606-13 p. digitalISSN:- 0016-5107
- Acute Disease
- Aged
- Anti-Inflammatory Agents -- pharmacology
- Cholangiopancreatography, Endoscopic Retrograde -- adverse effects
- Confounding Factors, Epidemiologic
- Double-Blind Method
- Female
- Heparin, Low-Molecular-Weight -- pharmacology
- Humans
- Male
- Middle Aged
- Pancreatitis -- etiology
- Prospective Studies
- Risk Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.